A detailed history of First Heartland Consultants, Inc. transactions in Amgen Inc stock. As of the latest transaction made, First Heartland Consultants, Inc. holds 2,445 shares of AMGN stock, worth $720,125. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,445
Previous 2,549 4.08%
Holding current value
$720,125
Previous $796,000 1.01%
% of portfolio
0.08%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$309.38 - $337.38 $32,175 - $35,087
-104 Reduced 4.08%
2,445 $788,000
Q2 2024

Jul 25, 2024

SELL
$262.75 - $319.31 $4,466 - $5,428
-17 Reduced 0.66%
2,549 $796,000
Q1 2024

May 07, 2024

SELL
$268.87 - $324.56 $2,957 - $3,570
-11 Reduced 0.43%
2,566 $730,000
Q4 2023

Feb 08, 2024

BUY
$255.7 - $288.46 $255 - $288
1 Added 0.04%
2,577 $742,000
Q2 2023

Jul 26, 2023

SELL
$214.27 - $253.37 $10,713 - $12,668
-50 Reduced 1.9%
2,576 $571,000
Q1 2023

Apr 17, 2023

BUY
$225.79 - $275.2 $451 - $550
2 Added 0.08%
2,626 $634,000
Q4 2022

Jan 13, 2023

BUY
$229.03 - $291.01 $2,290 - $2,910
10 Added 0.38%
2,624 $0
Q3 2022

Oct 20, 2022

BUY
$224.46 - $253.15 $11,223 - $12,657
50 Added 1.95%
2,614 $589,000
Q2 2022

Jul 12, 2022

BUY
$230.71 - $256.74 $6,229 - $6,931
27 Added 1.06%
2,564 $623,000
Q1 2022

Apr 21, 2022

BUY
$219.27 - $242.57 $4,604 - $5,093
21 Added 0.83%
2,537 $613,000
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $90,291 - $103,330
454 Added 22.02%
2,516 $566,000
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $49,246 - $57,698
-232 Reduced 10.11%
2,062 $439,000
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $100,672 - $111,689
-431 Reduced 15.82%
2,294 $559,000
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $44,160 - $51,461
199 Added 7.88%
2,725 $678,000
Q4 2020

Jan 29, 2021

SELL
$216.38 - $257.67 $86,119 - $102,552
-398 Reduced 13.61%
2,526 $581,000
Q3 2020

Oct 21, 2020

SELL
$234.65 - $260.95 $4,458 - $4,958
-19 Reduced 0.65%
2,924 $743,000
Q2 2020

Jul 16, 2020

BUY
$197.81 - $242.74 $2,571 - $3,155
13 Added 0.44%
2,943 $694,000
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $27,336 - $36,255
-150 Reduced 4.87%
2,930 $594,000
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $25,354 - $32,588
134 Added 4.55%
3,080 $743,000
Q3 2019

Nov 18, 2019

SELL
$174.11 - $208.62 $53,625 - $64,254
-308 Reduced 9.47%
2,946 $570,000
Q2 2019

Aug 12, 2019

BUY
$166.7 - $195.41 $13,502 - $15,828
81 Added 2.55%
3,254 $600,000
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $3,617 - $4,077
-20 Reduced 0.63%
3,173 $603,000
Q4 2018

Feb 12, 2019

SELL
$178.4 - $208.25 $1,070 - $1,249
-6 Reduced 0.19%
3,193 $622,000
Q3 2018

Nov 16, 2018

SELL
$185.29 - $208.89 $7,226 - $8,146
-39 Reduced 1.2%
3,199 $663,000
Q2 2018

Aug 09, 2018

SELL
$166.05 - $186.51 $76,383 - $85,794
-460 Reduced 12.44%
3,238 $598,000
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $167,905 - $196,218
991 Added 36.61%
3,698 $630,000
Q4 2017

Feb 26, 2018

SELL
$168.79 - $188.59 $342,306 - $382,460
-2,028 Reduced 42.83%
2,707 $471,000
Q3 2017

Nov 15, 2017

BUY
$167.29 - $191.0 $792,118 - $904,385
4,735
4,735 $883,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track First Heartland Consultants, Inc. Portfolio

Follow First Heartland Consultants, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Heartland Consultants, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Heartland Consultants, Inc. with notifications on news.